139 related articles for article (PubMed ID: 10823185)
21. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
[TBL] [Abstract][Full Text] [Related]
22. Osteomyelitis caused by Paracoccidioides brasiliensis in a child from the metropolitan area of Rio de Janeiro.
Nogueira SA; Guedes AL; Wanke B; Capella S; Rodrigues K; Abreu TF; Morais JC; Lambert JS
J Trop Pediatr; 2001 Oct; 47(5):311-5. PubMed ID: 11695735
[TBL] [Abstract][Full Text] [Related]
23. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
24. A randomized comparison of fluconazole with amphotericin B as empiric anti-fungal agents in cancer patients with prolonged fever and neutropenia.
Malik IA; Moid I; Aziz Z; Khan S; Suleman M
Am J Med; 1998 Dec; 105(6):478-83. PubMed ID: 9870832
[TBL] [Abstract][Full Text] [Related]
25. Amphotericin B lipid complex in the treatment of severe paracoccidioidomycosis: a case series.
Peçanha PM; de Souza S; Falqueto A; Grão-Veloso TR; Lírio LV; Ferreira CU; Santos AR; Costa HG; de Souza LR; Tuon FF
Int J Antimicrob Agents; 2016 Oct; 48(4):428-30. PubMed ID: 27612594
[TBL] [Abstract][Full Text] [Related]
26. Acute Paracoccidioidomycosis in a 40-Year-Old Man: A Case Report and Literature Review.
Ferreira Rocha L; de Araújo Torres D
Mycopathologia; 2017 Dec; 182(11-12):1095-1099. PubMed ID: 28900882
[TBL] [Abstract][Full Text] [Related]
27. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial.
Driessen M; Ellis JB; Cooper PA; Wainer S; Muwazi F; Hahn D; Gous H; De Villiers FP
Pediatr Infect Dis J; 1996 Dec; 15(12):1107-12. PubMed ID: 8970221
[TBL] [Abstract][Full Text] [Related]
28. The in-vivo activity of an antifungal antibiotic, benanomicin A, in comparison with amphotericin B and fluconazole.
Ohtsuka K; Watanabe M; Orikasa Y; Inouye S; Uchida K; Yamaguchi H; Kondo S; Takeuchi T
J Antimicrob Chemother; 1997 Jan; 39(1):71-7. PubMed ID: 9044030
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
[TBL] [Abstract][Full Text] [Related]
30. Activity and in vivo tracking of Amphotericin B loaded PLGA nanoparticles.
Souza AC; Nascimento AL; de Vasconcelos NM; Jerônimo MS; Siqueira IM; R-Santos L; Cintra DO; Fuscaldi LL; Pires Júnior OR; Titze-de-Almeida R; Borin MF; Báo SN; Martins OP; Cardoso VN; Fernandes SO; Mortari MR; Tedesco AC; Amaral AC; Felipe MS; Bocca AL
Eur J Med Chem; 2015 May; 95():267-76. PubMed ID: 25827397
[TBL] [Abstract][Full Text] [Related]
31. Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial.
Viscoli C; Castagnola E; Van Lint MT; Moroni C; Garaventa A; Rossi MR; Fanci R; Menichetti F; Caselli D; Giacchino M; Congiu M
Eur J Cancer; 1996 May; 32A(5):814-20. PubMed ID: 9081359
[TBL] [Abstract][Full Text] [Related]
32. Synergistic antifungal effect of fluconazole and human polymorphonuclear leukocytes on Paracoccidioides brasiliensis: effect of interferon-gamma and granulocyte-macrophage colony-stimulating factor.
Kurita N; Brummer E; Oarada M; Miyaji M
Med Mycol; 2003 Apr; 41(2):131-6. PubMed ID: 12964845
[TBL] [Abstract][Full Text] [Related]
33. The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Fong IW; Bannatyne RM; Cheng PC
Clin Invest Med; 1992 Oct; 15(5):434-9. PubMed ID: 1458716
[TBL] [Abstract][Full Text] [Related]
34. Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans.
Burgess DS; Hastings RW; Summers KK; Hardin TC; Rinaldi MG
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):13-8. PubMed ID: 10744363
[TBL] [Abstract][Full Text] [Related]
35. Relationship between intracranial pressure and antifungal agents levels in the CSF of patients with cryptococcal meningitis.
Wirth F; de Azevedo MI; Pilla C; Aquino VR; Neto GW; Goldani LZ
Med Mycol; 2018 Apr; 56(3):257-262. PubMed ID: 28992308
[TBL] [Abstract][Full Text] [Related]
36. Paracoccidioidomycosis in a woman with idiopathic hirsutism.
dos Santos RP; Maia AL; Goldani LZ
Mycopathologia; 2004 Jul; 158(1):57-9. PubMed ID: 15487322
[TBL] [Abstract][Full Text] [Related]
37. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents.
Yamamoto K; Makimura K; Sudo T; Shibuya K; Uchida K; Yamaguchi H
J Med Vet Mycol; 1997; 35(6):411-8. PubMed ID: 9467108
[TBL] [Abstract][Full Text] [Related]
38. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
Lombardi G; Gramegna G; Cavanna C; Michelone G
Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
[TBL] [Abstract][Full Text] [Related]
39. Acute Disseminated Paracoccidioidomycosis with Molluscoid Lesions in a Young Woman.
Di Martino Ortiz B; Moreno T; Galeano G; Rodríguez M
Actas Dermosifiliogr; 2015 Sep; 106(7):597-9. PubMed ID: 25665493
[No Abstract] [Full Text] [Related]
40. New 4-methoxy-naphthalene derivatives as promisor antifungal agents for paracoccidioidomycosis treatment.
Bagatin MC; F Rozada AM; V Rodrigues FA; A Bueno PS; Santos JL; Canduri F; Kioshima ÉS; V Seixas FA; Basso EA; Gauze GF
Future Microbiol; 2019 Feb; 14():235-245. PubMed ID: 30663901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
